Helius Med Technolog (HSDT) 0.9320 $HSDT Helius Medical

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Helius Med Technolog (HSDT) 0.9320 $HSDT

Helius Medical Technologies Appoints Thomas Griffin to Board of Directors and Chairman of the Audit Committee
Marketwire Canada - Mon Aug 08, 8:01AM CDT
NEWTOWN, PENNSYLVANIA--(Marketwired - Aug 8, 2016) - Helius Medical Technologies, Inc. (TSX:HSM)(OTCQB:HSDT) ("Helius" or the "Company" a company focused on the treatment of neurological symptoms caused by disease or trauma, announced today that Thomas Griffin will join the Board of Directors, effective immediately. Mr. Griffin will also serve as Chairman of the Audit Committee.
ENTL: 18.13 (-0.22), HSM.TO: 1.16 (unch)

Helius Medical Announces Results from a Case Series of Subjects With Advanced MS
Marketwire Canada - Tue Jun 21, 8:03AM CDT
NEWTOWN, PENNSYLVANIA--(Marketwired - Jun 21, 2016) - Helius Medical Technologies, Inc. (TSX:HSM)(TSX:HSM.S)(OTCQB:HSDT) ("Helius" or the "Company" is pleased to announce the results of a case series of individuals with advanced symptoms of Multiple Sclerosis (MS) treated with PoNS™ Therapy.
HSM.TO: 1.16 (unch), HSM-S.TO: 1.15 (-0.12)

Helius Medical Announces Proceeds of $1.4 Million From Exercise of Warrants
Marketwired - Mon Jun 06, 8:03AM CDT
NEWTOWN, PENNSYLVANIA--(Marketwired - Jun 6, 2016) - Helius Medical Technologies, Inc. (TSX:HSM)(OTCQB:HSDT) ("Helius" or the "Company" a medical technology company focused on the treatment of neurological symptoms caused by disease or trauma, is pleased to announce that it received proceeds of CDN $1,825,600 (approximately US$1,409,947) from the exercise of certain warrants issued in 2014, all of which was received after the Company's fiscal year end on March 31, 2016.
HSM.TO: 1.16 (unch)

Helius Medical Technologies Restates and Re-Files Historical Financial Statements for Non-Cash Reclassification of Warrants
Marketwired - Tue Apr 26, 4:06PM CDT
Helius Medical Technologies, Inc. (TSX: HSM)(OTCQB: HSDT) ("Helius" or the "Company" - The Company is issuing the following press release to clarify its disclosure.
HSM.TO: 1.16 (unch)

CSE: 2016-0408 - Delist - Helius Medical Technologies Inc. (HSM)
Marketwired - Mon Apr 18, 10:30AM CDT
The common shares of Helius Medical Technologies Inc. will be delisted at the market close today, April 18, 2016.

IIROC Trade Resumption - Helius Medical Technologies, Inc.
Newsfile Corp - Mon Apr 18, 8:25AM CDT
Trading resumes in:

IIROC Trade Resumption - HSM.S
CNW Group - Mon Apr 18, 8:24AM CDT
Trading resumes in:

IIROC Trade Halt - Helius Medical Technologies, Inc. Reg S Shares
Newsfile Corp - Mon Apr 18, 7:27AM CDT
The following issues have been halted by IIROC:

Helius Medical Technologies Restates and Re-files Historical Financial Statements
TheNewswire.ca - Mon Jan 11, 7:30AM CST
(via Thenewswire.ca)

Helius Medical Technologies Announces Allowances of 10 New Patents
BusinessWire - Mon Jan 04, 4:43PM CST
Helius Medical Technologies, Inc. (CSE:HSM; OTCQB:HSDT) ("Helius", or the "Company", a medical technology company focused on the treatment of neurological symptoms caused by disease or trauma, announced today that ten (10) new patent applications (seven US and three Chinese) have been allowed by the US and Chinese Patent Offices in November and December 2015 building on the already strong patent portfolio of the company. The Company has a further 33 patents (22 US and 11 international) pending on its technology in the US and other markets around the world.

Helius Medical Technologies Announces Receipt of Remainder of A&B Funding, Changes to Board of Directors, and Extension of CRADA Agreement Through December 2017
BusinessWire - Thu Dec 31, 5:03PM CST
Helius Medical Technologies, Inc. (CSE:HSM; OTCQB:HSDT) ("Helius", or the "Company", a medical technology company focused on the treatment of neurological symptoms caused by disease or trauma, today announced that the Company has elected to draw down on the remaining USD $5 million credit facility from A&B (HK) Company Limited ("A&B", appointed two new members to its Board of Directors and obtained an extension to its Cooperative Research and Development Agreement ("CRADA" with the US Army Medical Research and Material Command ("USAMRMC".

Helius Medical Technologies Announces Positive Clinical Trial Results from its Multiple Sclerosis Pilot Study
BusinessWire - Mon Nov 02, 8:23AM CST
Helius Medical Technologies, Inc. (CSE: HSM; OTCQB: HSDT) ("Helius", or the "Company", a medical technology company focused on the treatment of neurological symptoms caused by disease or trauma, announced today that the Multiple Sclerosis ("MS" pilot study evaluating its investigational Portable Neuromodulation Stimulator ("PoNS(TM)" device, met all of its study objectives. A total of 14 subjects (7-active and 7-sham control) received treatment with the non-invasive brain stimulation technology and concomitant physiotherapy. The independent trial took place at the Montreal Neurological Institute and Hospital and Concordia University's PERFORM Center. The study objectives were to explore the potential beneficial effects of PoNS(TM) stimulation, as previously reported, and to provide data to be used for the design of future studies to support requests for marketing authorization. The study included the first use of Functional MRI ("fMRI" to measure the effect of PoNS(TM) while performing tasks with, and without, stimulation.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 212

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 245

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 375

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 213

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 238

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 262

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 377

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 301

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 192

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 417

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading

Top 5 Most Recently Viewed Articles

APT Miner Mobile App Revolutionizes Cloud Mining Experience

Updated Category News Views 352

APT Miner Mobile App: A New Era in Cryptocurrency Mining APT Miner has launched a groundbreaking mobile application that opens the door to easy cryptocurrency mining for everyone. With this new app, users can seamlessly engage in mining operations from their mobile devices, without the need for technical expertise or complicated setups. The platform caters to a wide range...

Continue Reading
Investors Urged to Act Before September Deadline in Alto Case

Updated Category News Views 233

Important Announcement for Alto Neuroscience Investors In a recent advisory, investors of Alto Neuroscience, Inc. (NYSE: ANRO) are being urged to secure legal counsel as the deadline for a pivotal class action lawsuit approaches. The deadline for lead plaintiffs to step forward is September 19, 2025, providing investors who are affected by a range of factors related to...

Continue Reading
Strategic Sale: McStarlite Co. Partners with Standex International

Updated Category News Views 244

Strategic Changes Ahead for McStarlite Co. In a significant move, Janes Capital Partners has announced its role as the exclusive advisor for McStarlite Co. in its acquisition by Standex International Corporation (NYSE:SXI). This partnership highlights Janes Capital Partners’ capability to navigate complex transactions in the aerospace sector. McStarlite Co.: A Leader in...

Continue Reading
Codis Accelerates Growth with 1315 Capital Investment

Updated Category News Views 185

Codis Secures Funding for Expansion Codis, a leading contract development and manufacturing organization (CDMO) specializing in spray drying and related technologies, is excited to announce a significant growth investment from 1315 Capital. This partnership aims to bolster Codis's manufacturing capabilities significantly, particularly at its Haverhill facility in the UK....

Continue Reading
A Decade of Growth: The Journey of an Investment in Guidewire

Updated Category News Views 174

The Growth Journey of Guidewire Software Guidewire Software (GWRE) has seen significant advancements in the last decade, marking an impressive annualized return of 17.03%. Over this period, it has outperformed the broader market by 4.38%, which speaks volumes about the company’s stability and growth potential. Understanding Guidewire’s Market Position With a current...

Continue Reading